Contextualizing Violence Risk Associated With Hallucinogens
FOCUS The Journal of Lifelong Learning in Psychiatry – January 01, 2026
Source: OpenAlex
Summary
Psychedelics like psilocybin, LSD, and MDMA show promise in treating mental illness but their relationship with aggression is complex. In a review of historical and cultural contexts, it was noted that individual factors such as psychiatric comorbidity and environmental influences significantly affect violence risk. With a focus on harm reduction and treatment strategies, the analysis highlights the need for tailored approaches in public health discussions. Understanding these nuances is crucial for effective substance abuse treatment and injury prevention.
Abstract
Psilocybin, lysergic acid diethylamide (LSD), and 3,4-methylenedioxymethamphetamine (MDMA) have remerged as agents of psychiatric and cultural relevance. However, public discourse has outpaced empirical understanding of their effects. Although hallucinogens have demonstrated a potential to treat certain mental disorders, their effect on aggression and violence risk remains inconclusive. This article reviews the historical, medical, legal, and cultural contexts of these popular psychedelic and entactogenic compounds. The impact of substance type, dose, set and setting, psychiatric comorbidity, and environmental factors on violence is reviewed. Prevention and response strategies relevant to hallucinogenic compounds are discussed, including harm reduction, risk assessment, and treatment. Individual risk factors that mediate violence risk for people who consume psilocybin, LSD, and MDMA remain an area for further research.